(I-Newswire) - Los Angeles, CA - The Institute for Myeloma and Bone Cancer Research ( IMBCR ) is the only independent, non-profit cancer research institute working to find improved treatment and ultimately, a cure for multiple myeloma – a rare hematological cancer ( cancer of the blood cells ) that reside in the bone marrow. The American Cancer Society predicts that over 60,000 people are currently living with myeloma and over 16,000 new cases are diagnosed each year. Approximately 10,000 people die each year from multiple myeloma.
